有机阳离子转运蛋白
血脑屏障
运输机
药理学
有机阴离子转运蛋白1
药物输送
化学
溶质载体族
胆碱
药品
医学
中枢神经系统
生物化学
内科学
基因
有机化学
作者
Werner J. Geldenhuys,David Allen
出处
期刊:Central nervous system agents in medicinal chemistry
[Bentham Science]
日期:2012-06-01
卷期号:12 (2): 95-99
被引量:18
标识
DOI:10.2174/187152412800792670
摘要
Drug delivery to the brain is made difficult by the blood-brain barrier (BBB) which is selectively permeable to organic drug compounds. Several membrane solute and nutrient transporters are expressed in the BBB vasculature, which may be utilized as mechanism of delivery of drugs to the brain. Of interest to us, are the organic cation transporters which could be used to transport cationic compounds into the CNS. In this mini-review, we will review the current understanding of the structural requirements for designing compounds which could effectively use organic cation transporters (OCT). For the first time, structural requirements for both OCT1 and OCT2 versus the BBB choline transporter (BBBCHT) are discussed and compared. The information gained here could increase the success rate in successful CNS drug delivery and therapeutics. Keywords: In situ brain perfusion, logPS, organic cation transporters, OCT, SLC22A, donepezil, CNS permeability, blood-brain barrier (BBB)
科研通智能强力驱动
Strongly Powered by AbleSci AI